Leaders from the European Society for Medical Oncology discuss survey data on gender gaps in oncology and propose solutions to close these gaps between men and women professionally.

Dr John Marshall discusses new science in pancreatic and colorectal cancers, presented at the 2018 Gastrointestinal Cancers Symposium.

Set up to improve access to anti-cancer orphan drugs, the CDF did not live up to its promise, says Dr Kerr.

Drs Ann LaCasce and Caron Jacobson on how these and other treatments may change your practice in the new year.

Drs Cortes and DeAngelo highlight the most intriguing clinical trials presented in the field of leukemia at ASH 2017.

Dr Mark Kris on how 2017 clarified the importance of achieving progression-free survival in lung cancer patients.

Dr Kerr reports on a large, well-designed trial with disappointing results.

A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.

Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.

Evaluation of biomarkers after 5 years of standard therapy for hormone-positive breast cancer may help determine those at risk for recurrence and those who may need further endocrine therapy.